TP Therapeutics is a clinical-stage structure-based drug design company which discovers and develops precision medicines for cancer and other diseases. The Company is focusing on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating tumor microenvironment and tumor immunity.
|HQ||San Diego, US||Map|
|Employees (est.) (Feb 2019)||31|
TP Therapeutics total Funding
TP Therapeutics latest funding size
Time since last funding
|4 months ago|
TP Therapeutics investors
|Nextech Invest, venBio Partners, SR One, Foresite Capital, Lilly Asia Ventures, HBM Healthcare Investments AG, Cormorant Asset Management|
TP Therapeutics has 64 Twitter Followers. The number of followers has increased 7.6% month over month and increased 19.4% quarter over quarter
When was TP Therapeutics founded?
TP Therapeutics was founded in 2013.
Who are TP Therapeutics key executives?
TP Therapeutics's key executives are J. Jean Cui.
How many employees does TP Therapeutics have?
TP Therapeutics has 31 employees.
Who are TP Therapeutics competitors?
Competitors of TP Therapeutics include CytomX Therapeutics, Merrimack Pharmaceuticals and TESARO.
Where is TP Therapeutics headquarters?
TP Therapeutics headquarters is located at 225 10628 Science Center Dr, San Diego.
Where are TP Therapeutics offices?
TP Therapeutics has an office in San Diego.
How many offices does TP Therapeutics have?
TP Therapeutics has 1 office.